Avadel Pharmaceuticals (AVDL) Revenue (2016 - 2020)
Historic Revenue for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $10.1 million.
- Avadel Pharmaceuticals' Revenue fell 4251.45% to $10.1 million in Q2 2020 from the same period last year, while for Mar 2021 it was $10.1 million, marking a year-over-year decrease of 8165.97%. This contributed to the annual value of -$10.8 million for FY2024, which is N/A changed from last year.
- As of Q2 2020, Avadel Pharmaceuticals' Revenue stood at $10.1 million, which was down 4251.45% from $12.2 million recorded in Q1 2020.
- In the past 5 years, Avadel Pharmaceuticals' Revenue registered a high of $52.5 million during Q1 2017, and its lowest value of $10.1 million during Q2 2020.
- Its 5-year average for Revenue is $28.3 million, with a median of $30.7 million in 2016.
- Per our database at Business Quant, Avadel Pharmaceuticals' Revenue skyrocketed by 1800800.0% in 2016 and then tumbled by 5062.93% in 2019.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Revenue stood at $43.1 million in 2016, then dropped by 19.34% to $34.8 million in 2017, then tumbled by 39.8% to $20.9 million in 2018, then crashed by 47.44% to $11.0 million in 2019, then fell by 8.22% to $10.1 million in 2020.
- Its last three reported values are $10.1 million in Q2 2020, $12.2 million for Q1 2020, and $11.0 million during Q4 2019.